March 26, 2018 / 11:30 AM / 4 months ago

BRIEF-BioLineRx Announces Notice of Allowance From USPTO for Patent Covering Immunotherapy for Treating Solid Tumors

March 26 (Reuters) - Bioline Rx Ltd:

* BIOLINERX ANNOUNCES NOTICE OF ALLOWANCE FROM USPTO FOR PATENT COVERING AGI-134 - A NOVEL IMMUNOTHERAPY FOR TREATING SOLID TUMORS

* BIOLINE RX LTD - ‍THIS PATENT, WHEN ISSUED, WILL BE VALID UNTIL MAY 2035 WITH A POSSIBILITY OF UP TO FIVE YEARS PATENT TERM EXTENSION​

* BIOLINE RX LTD - ‍ADDITIONAL CORRESPONDING PATENT APPLICATIONS FOR AGI-134 ARE PENDING IN EUROPE, JAPAN, CHINA, CANADA, AUSTRALIA AND ISRAEL​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below